StockData
ProMIS Neurosciences Inc. logo

ProMIS Neurosciences Inc. (PMN) stock

PMNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$3.21−0.10 (-3.02%)

Close on Nov 17, 2026Market cap $28.79MP/E –Yield –

ProMIS Neurosciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

ProMIS Neurosciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$42.11M. For fiscal 2025 it was -$28.12M. The highest annual figure on record is -$9.31M in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$28.12M–
FY2024Dec 31, 2024-$27.18M–
FY2023Dec 31, 2023-$10.84M–
FY2022Dec 31, 2022-$17.03M–
FY2021Dec 31, 2021-$9.31M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$10.39M–
Q1 FY2026Mar 31, 2026-$12.38M–
Q4 FY2025Dec 31, 2025-$9.28M–
Q3 FY2025Sep 30, 2025-$10.06M–
Q2 FY2025Jun 30, 2025-$3.85M–
Q1 FY2025Mar 31, 2025-$4.93M–
Q4 FY2024Dec 31, 2024-$8.72M–
Q3 FY2024Sep 30, 2024-$6.67M–
Q2 FY2024Jun 30, 2024-$1.50M–
Q1 FY2024Mar 31, 2024-$10.29M–
Q4 FY2023Dec 31, 2023-$3.76M–
Q3 FY2023Sep 30, 2023-$2.38M–
Q2 FY2023Jun 30, 2023-$2.15M–
Q1 FY2023Mar 31, 2023-$2.56M–
Q4 FY2022Dec 31, 2022-$4.55M–
Q3 FY2022Sep 30, 2022-$4.64M–
Q2 FY2022Jun 30, 2022-$4.48M–
Q1 FY2022Mar 31, 2022-$3.37M–
Q4 FY2021Dec 31, 2021-$4.05M–
Q3 FY2021Sep 30, 2021-$3.03M–

More ProMIS Neurosciences figures

See a number that looks wrong?